(Q46934801)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17957221%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

title

Naltrexone attenuates the subjective effects of amphetamine in patients with amphetamine dependence (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17957221%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

0 references

0 references

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17957221%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Nitya Jayaram-Lindström

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17957221%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

2

Maija Konstenius

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17957221%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

author name string

Staffan Eksborg

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17957221%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Anders Hammarberg

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17957221%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Johan Franck

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17957221%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

language of work or name

English

0 references

publication date

24 October 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17957221%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

published in

Neuropsychopharmacology

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17957221%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

volume

33

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17957221%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

issue

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17957221%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

page(s)

1856-1863

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17957221%20AND%20SRC:MED&resulttype=core&format=json

Statistical estimations in pharmacokinetics.

9 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301572

JANA: a new iterative polyexponential curve stripping program.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301572

Temporal upregulation of prodynorphin mRNA in the primate striatum after cocaine self-administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301572

Imaging brain mu-opioid receptors in abstinent cocaine users: time course and relation to cocaine craving

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301572

Effects of naloxone on d-amphetamine- and apomorphine-induced behavior

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301572

In vivo neurochemical profile of dopamine uptake inhibitors and releasers in rat caudate-putamen

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301572

A comparison of methamphetamine-dependent inpatients childhood attention deficit hyperactivity disorder symptomatology

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301572

Effects of naltrexone on the subjective response to amphetamine in healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301572

Naloxone augments the hypothalamic-pituitary-adrenal axis response to methylphenidate in normal subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301572

Naloxone depresses cocaine self-administration and delays its initiation on the following day.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301572

Intravenous cocaine challenges during naltrexone maintenance: a preliminary study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301572

Naloxone inhibits the reinforcing and motivational aspects of cocaine addiction in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301572

The effect of intravenous methamphetamine on mood

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301572

Anticraving medications for relapse prevention: a possible new class of psychoactive medications

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301572

The effects of naltrexone on alcohol and cocaine use in dually addicted patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301572

Naltrexone and relapse prevention treatment for cocaine-dependent patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301572

Treatment of cocaine-alcohol dependence with naltrexone and relapse prevention therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301572

Effects of naltrexone and isradipine, alone or in combination, on cocaine responses in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301572

The development of a cocaine craving questionnaire

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301572

Naloxone blockade of amphetamine place preference conditioning

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301572

Naloxone suppression of self-stimulation is independent of response difficulty

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301572

Medications development: successes and challenges

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301572

Naltrexone in the treatment of alcohol dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301572

A multicentre, randomized, double-blind, placebo-controlled trial of naltrexone in the treatment of alcohol dependence or abuse

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301572

7 January 2021

Physiologic, subjective, and behavioral effects of amphetamine, methamphetamine, ephedrine, phenmetrazine, and methylphenidate in man

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301572

7 January 2021

Naloxone effects on ?-endorphin, cortisol, prolactin, growth hormone, HVA and MHPG in plasma of normal volunteers

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301572

7 January 2021

Naltrexone and coping skills therapy for alcohol dependence. A controlled study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301572

7 January 2021

Treatment for amphetamine dependence and abuse.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301572

7 January 2021

Alterations in striatal zif/268, preprodynorphin and preproenkephalin mRNA expression induced by repeated amphetamine administration in rats

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301572

7 January 2021